---
figid: PMC6347283__JME-18-0058fig2
figlink: /pmc/articles/PMC6347283/figure/fig2/
number: F2
caption: Schematic representation of effectors downstream of MTORC1. MTORC1 controls
  various metabolic processes via transcriptional and/or translational regulation.
  MTORC1 stimulates nucleotide synthesis (via ATF4), pentose phosphate pathway and
  lipid biosynthesis (via SREBP1), adipogenesis (via PPARG), glutamine metabolism
  (via ATF2 and MYC) and mitochondrial biogenesis (via PPARGC1A and YY1). The MTORC1/RPS6KB
  axis stimulates SREBP1 and CAD, which are essential for lipid and nucleotide biosynthesis,
  respectively. MTORC1 also stimulates lipid synthesis by controlling the nuclear
  localization of LPIN1, a negative regulator of SREBP1. In addition, MTORC1 phosphorylates
  LPIN1, facilitating its role as a coactivator for PPARG during adipogenesis. To
  date, the best characterized mediators of the effects of MTOR on protein synthesis
  are EIF4EBPs and RPS6KBs. MTOR stimulates the EIF4F complex assembly (comprised
  of EIF4E, EIF4G and EIF4A), by inactivating EIF4EBPs. In turn, RPS6KBs phosphorylate
  components of the translational machinery (PDCD4, RPS6, EIF4B and EEF2K). In respect
  to cancer energetics, the MTORC1/EIF4EBP/EIF4F axis regulates translation of mRNAs
  encoding mitochondrial factors (e.g. TFAM, ATP5O), central metabolic regulators
  (MYC and HIF1A) and enzymes involved in NEAA synthesis (PHGDH, PSAT1, PC and ASNS).
  The effects of EIF4A inhibitors and SBI-756 on MTOR-dependent translational and
  metabolic programs in explained within the text. ATF4, activating transcription
  factor 4; SREBP1, sterol regulatory element-binding transcription factor 1; PPARG,
  peroxisome proliferator-activated receptor gamma; ATF2, activating transcription
  factor 2; PPARGC1A, peroxisome proliferator-activated receptor gamma coactivator
  1-alpha; YY1, Yin-Yang 1; RPS6KB, ribosomal protein S6 kinase; CAD, carbamoyl-phosphate
  synthetase 2, aspartate transcarbamylase, and dihydroorotase; LPIN1, lipin 1; EIF4EBP,
  eukaryotic initiation factor 4E-binding protein; EIF, eukaryotic initiation factor;
  PDCD4, programmed cell death 4; RPS6, ribosomal protein S6; EEF2K, eukaryotic elongation
  factor 2 kinase; TFAM, transcription factor A, mitochondrial; ATP5O, ATP synthase
  subunit O; HIF1A, hypoxia-inducible factor 1A; PRPS2, phosphoribosyl pyrophosphate
  synthetase 2; PHDH, phosphoglycerate dehydrogenase; PSAT1, phosphoserine aminotransferase1;
  PC, pyruvate carboxylase; ASNS, asparagine synthetase.
pmcid: PMC6347283
papertitle: Oncogenic kinases and perturbations in protein synthesis machinery and
  energetics in neoplasia.
reftext: Oro Uchenunu, et al. J Mol Endocrinol. 2019 Feb;62(2):R83-R103.
pmc_ranked_result_index: '43860'
pathway_score: 0.9398084
filename: JME-18-0058fig2.jpg
figtitle: Effectors downstream of MTORC1
year: '2019'
organisms: Homo sapiens
ndex: b4ab722a-df00-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6347283__JME-18-0058fig2.html
  '@type': Dataset
  description: Schematic representation of effectors downstream of MTORC1. MTORC1
    controls various metabolic processes via transcriptional and/or translational
    regulation. MTORC1 stimulates nucleotide synthesis (via ATF4), pentose phosphate
    pathway and lipid biosynthesis (via SREBP1), adipogenesis (via PPARG), glutamine
    metabolism (via ATF2 and MYC) and mitochondrial biogenesis (via PPARGC1A and YY1).
    The MTORC1/RPS6KB axis stimulates SREBP1 and CAD, which are essential for lipid
    and nucleotide biosynthesis, respectively. MTORC1 also stimulates lipid synthesis
    by controlling the nuclear localization of LPIN1, a negative regulator of SREBP1.
    In addition, MTORC1 phosphorylates LPIN1, facilitating its role as a coactivator
    for PPARG during adipogenesis. To date, the best characterized mediators of the
    effects of MTOR on protein synthesis are EIF4EBPs and RPS6KBs. MTOR stimulates
    the EIF4F complex assembly (comprised of EIF4E, EIF4G and EIF4A), by inactivating
    EIF4EBPs. In turn, RPS6KBs phosphorylate components of the translational machinery
    (PDCD4, RPS6, EIF4B and EEF2K). In respect to cancer energetics, the MTORC1/EIF4EBP/EIF4F
    axis regulates translation of mRNAs encoding mitochondrial factors (e.g. TFAM,
    ATP5O), central metabolic regulators (MYC and HIF1A) and enzymes involved in NEAA
    synthesis (PHGDH, PSAT1, PC and ASNS). The effects of EIF4A inhibitors and SBI-756
    on MTOR-dependent translational and metabolic programs in explained within the
    text. ATF4, activating transcription factor 4; SREBP1, sterol regulatory element-binding
    transcription factor 1; PPARG, peroxisome proliferator-activated receptor gamma;
    ATF2, activating transcription factor 2; PPARGC1A, peroxisome proliferator-activated
    receptor gamma coactivator 1-alpha; YY1, Yin-Yang 1; RPS6KB, ribosomal protein
    S6 kinase; CAD, carbamoyl-phosphate synthetase 2, aspartate transcarbamylase,
    and dihydroorotase; LPIN1, lipin 1; EIF4EBP, eukaryotic initiation factor 4E-binding
    protein; EIF, eukaryotic initiation factor; PDCD4, programmed cell death 4; RPS6,
    ribosomal protein S6; EEF2K, eukaryotic elongation factor 2 kinase; TFAM, transcription
    factor A, mitochondrial; ATP5O, ATP synthase subunit O; HIF1A, hypoxia-inducible
    factor 1A; PRPS2, phosphoribosyl pyrophosphate synthetase 2; PHDH, phosphoglycerate
    dehydrogenase; PSAT1, phosphoserine aminotransferase1; PC, pyruvate carboxylase;
    ASNS, asparagine synthetase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPARGC1A
  - PPARG
  - EIF4G2
  - GLUD1
  - ASNS
  - EIF4A1
  - EIF4A2
  - GLS
  - EEF2K
  - EIF4E
  - EIF4EBP3
  - EIF4A3
  - EIF4B
  - EIF4G3
  - EIF4G1
  - MYC
  - PC
  - PDCD4
  - PHGDH
  - MTOR
  - HIF1A
  - MCL1
  - MTHFD2
  - ATF4
  - EIF4EBP1
  - ATF2
  - RPS6
  - BCL2
  - CAD
  - EEF2
  - SIRT4
  - STAT3
  - EIF4EBP2
  - RPTOR
genes:
- word: (PPARGC1A
  symbol: PPARGC1A
  source: hgnc_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: (PPARG
  symbol: PPARG
  source: hgnc_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: EIF4G
  symbol: EIF4G
  source: bioentities_symbol
  hgnc_symbol: EIF4G2
  entrez: '1982'
- word: (GLUD1
  symbol: GLUD1
  source: hgnc_symbol
  hgnc_symbol: GLUD1
  entrez: '2746'
- word: (PHGDH,PC,ASNS,PSATT)
  symbol: ASNS
  source: hgnc_symbol
  hgnc_symbol: ASNS
  entrez: '440'
- word: EIF4A
  symbol: EIF4A
  source: bioentities_symbol
  hgnc_symbol: EIF4A1
  entrez: '1973'
- word: EIF4A
  symbol: EIF4A
  source: bioentities_symbol
  hgnc_symbol: EIF4A2
  entrez: '1974'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: (EEF2K
  symbol: EEF2K
  source: hgnc_symbol
  hgnc_symbol: EEF2K
  entrez: '29904'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: EIF4EBP
  symbol: EIF4EBP
  source: bioentities_symbol
  hgnc_symbol: EIF4EBP3
  entrez: '8637'
- word: EIF4A
  symbol: EIF4A
  source: bioentities_symbol
  hgnc_symbol: EIF4A3
  entrez: '9775'
- word: (EIF4B
  symbol: EIF4B
  source: hgnc_symbol
  hgnc_symbol: EIF4B
  entrez: '1975'
- word: EIF4G
  symbol: EIF4G
  source: bioentities_symbol
  hgnc_symbol: EIF4G3
  entrez: '8672'
- word: EIF4G
  symbol: EIF4G
  source: bioentities_symbol
  hgnc_symbol: EIF4G1
  entrez: '1981'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PC,
  symbol: PC
  source: hgnc_symbol
  hgnc_symbol: PC
  entrez: '5091'
- word: PDCD4)
  symbol: PDCD4
  source: hgnc_symbol
  hgnc_symbol: PDCD4
  entrez: '27250'
- word: (PHGDH,
  symbol: PHGDH
  source: hgnc_symbol
  hgnc_symbol: PHGDH
  entrez: '26227'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HIF1A)
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: MCL1,
  symbol: MCL1
  source: hgnc_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: MTHFD2
  symbol: MTHFD2
  source: hgnc_symbol
  hgnc_symbol: MTHFD2
  entrez: '10797'
- word: ATF4
  symbol: ATF4
  source: hgnc_symbol
  hgnc_symbol: ATF4
  entrez: '468'
- word: EIF4EBP
  symbol: EIF4EBP
  source: bioentities_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: EIF4F
  symbol: EIF4F
  source: hgnc_prev_symbol
  hgnc_symbol: EIF4A2
  entrez: '1974'
- word: ATF2
  symbol: ATF2
  source: hgnc_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: RPS6)
  symbol: RPS6
  source: hgnc_symbol
  hgnc_symbol: RPS6
  entrez: '6194'
- word: (BCL2,
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: CAD
  symbol: CAD
  source: hgnc_symbol
  hgnc_symbol: CAD
  entrez: '790'
- word: EEF2
  symbol: EEF2
  source: hgnc_symbol
  hgnc_symbol: EEF2
  entrez: '1938'
- word: SIRT4
  symbol: SIRT4
  source: hgnc_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: EIF4EBP
  symbol: EIF4EBP
  source: bioentities_symbol
  hgnc_symbol: EIF4EBP2
  entrez: '1979'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
chemicals: []
diseases: []
figid_alias: PMC6347283__F2
redirect_from: /figures/PMC6347283__F2
figtype: Figure
---
